STAT1 and hepatocellular carcinoma: As atorvastatin was demonstrated to dose-dependently inhibit STAT1 phosphorylation [18], we hypothesized that atorvastatin might have an effect on the IFNγ induced expression of PD-L1 in HCC cells.